Online Journal
IF値: 0.677(2017年)→0.966(2018年)


Journal of Medical Ultrasonics

にて英文誌のFull textを閲覧することができます.


1995 - Vol.22

Vol.22 No.01

Original Article(原著)

(0019 - 0026)


Observation of Myocardial Contrast Enhancement by transvenous Intracardiac Echocardiography: An Experimental Study

鎌田 智彦1, 森内 正人1, 谷川 直1, 福井 利章1, 高山 忠輝1, 本江 純子1, 斎藤 穎1, 小沢 友紀雄1, 上松瀬 勝男1, 島ノ江 信芳2

Tomohiko KAMATA1, Masahito MORIUCHI1, Naoshi TANIGAWA1, Toshiaki FUKUI1, Tadateru TAKAYAMA1, Junko HONYE1, Satoshi SAITO1, Yukio OZAWA1, Katsuo KANMATSUSE1, Nobuyoshi SHIMANOE2

1日本大学第2内科, 2アロカ(株)

1Second Department of Internal Medicine, Nihon University School of Medicine, 2Aloka Inc.

キーワード : Left atrial injection, Myocardial contrast, Myocardial perfusion, Peak intensity, Transvenous intracardiac echocardiography

We evaluated the usefulness of transvenous intracardiac echocardiography (TVE) in visualizing the myocardial contrast effect in dogs in vivo. A 7-mm transesophageal echo probe (5 MHz, Aloka, Inc.) was introduced into the femoral vein and advanced into the right atria of 14 anesthetized dogs. The tip of the probe was positioned to allow visualization of the left ventricle in it's short-axis view. Albunex® was injected into the left coronary artery (n=14) or the left atrium (n=11) while contrast effect was continuously monitored by TVE. The results indicate that TVE can provide continuous, high-quality images of the heart. Moreover, the observed myocardial contrast effect had a high degree of reproducibility. Correlation between peak intensity produced by the first and second Albunex® injections was excellent in terms of both anteroseptal area (r=0.90, n=14) and posterior area (r=0.84, n=10). Injection of Albunex® into the left coronary artery during LAD or LCX ligation (n=5) produced extremely clear demarcation between perfused and non-perfused areas. The myocardial contrast effect was also observed when Albunex® was injected into the left atrium (100%-Albunex, 11/11, 100%). Peak intensities in the anterior region after the first and second left atrial injections (n=11) were closely correlated. Because of excessive contrast enhancement of the left ventricular cavity, however, detection of myocardial contrast in the posterior region was difficult in 4 of the dogs subjected to left coronary injection and in all of those subjected to left atrial injection. This experimental study would thus appear to indicate that TVE is a sensitive method of observing the myocardial contrast effect that produces highly reproducible results. TVE also appears to be especially useful for continuous monitoring of ventricular wall motion and myocardial perfusion status during myocardial ischemia. Future application of this technique to humans in vivo will be useful in the precise identification of perfused areas, and may enhance the clinical value of contrast echocardiography.